Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
Top Cited Papers
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 118 (3) , 463-468
- https://doi.org/10.1016/s0016-5085(00)70251-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestineGastroenterology, 1998
- Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transitClinical Pharmacology & Therapeutics, 1997
- First Pharmacokinetic—Pharmacodynamic Study in Humans with a Selective 5‐Hydroxytryptamine4 Receptor AgonistThe Journal of Clinical Pharmacology, 1997
- Bran and irritable bowel syndrome: time for reappraisalThe Lancet, 1994
- CisaprideDrugs, 1994
- The Irritable Bowel Syndrome: Mechanisms and a Practical Approach to ManagementAnnals of Internal Medicine, 1992
- Towards a less costly but accurate test of gastric emptying and small bowel transitDigestive Diseases and Sciences, 1991
- “Prokinetic” Treatment of Constipation-Predominant Irritable Bowel SyndromeJournal of Clinical Gastroenterology, 1991
- Simplified assessment of segmental colonic transitGastroenterology, 1987
- Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns.Gut, 1983